Please assess the completion status of the following clinical trial:

Trial Title: Evaluating How the Treatments in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Affect Diabetic Retinopathy (The ACCORD Eye Study)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 6.0

Eligibility Criteria:
Inclusion Criteria:~* Participating in the ACCORD study~Exclusion Criteria:~* Has had laser photocoagulation for DR~* Has had vitrectomy surgery for DR

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 79 Years
- Healthy Volunteers: f

Study Arms:
- Intensive glycemia control (Type: EXPERIMENTAL): A strategy of intensive glycemia treatment to HbA1c less than 6%
- Standard glycemia control (Type: ACTIVE_COMPARATOR): A strategy of multiple drugs to treat HbA1c to 7.0% - 7.9%
- Intensive BP control (Type: EXPERIMENTAL): A strategy of BP treatment for SBP less than 120 mm Hg
- Standard BP control (Type: ACTIVE_COMPARATOR): A strategy of BP treatment for SBP less than 140 mm Hg
- Fibrate (Type: EXPERIMENTAL): Blinded fenofibrate + simvastatin 20-40 mg/d
- Fibrate Placebo (Type: PLACEBO_COMPARATOR): Blinded placebo + simvastatin 20-40 mg/d

Based on this trial design, predict the completion outcome and termination type (if applicable).